Primary Immunodeficiency, PID, and autoimmune disease such as SLE can cause severe impairments and represent a considerable health care burden. Effective treatment for these immune disorders are urgently needed. The EPSC technology offers new opportunities to understand the cellular and molecular nature of these diseases.